Heterologous prime-boost immunization with vesiculovirus-based vectors expressing HBV Core antigen induces CD8

Animals CD8-Positive T-Lymphocytes / immunology Genetic Vectors Hepatitis B / immunology Hepatitis B Core Antigens / genetics Hepatitis B Vaccines / administration & dosage Hepatitis B virus / genetics Immunization, Secondary Liver / immunology Male Mice Mice, Inbred C57BL Semliki forest virus / genetics Vaccination Vaccines, Attenuated Vaccines, Virus-Like Particle Vesicular stomatitis Indiana virus / genetics Vesiculovirus / genetics Virus Replication
AAV Core antigen HBV Prime-boost VSV Virus-based vectors

Journal

Antiviral research
ISSN: 1872-9096
Titre abrégé: Antiviral Res
Pays: Netherlands
ID NLM: 8109699

Informations de publication

Date de publication:
08 2019
Historique:
received: 23 03 2019
revised: 24 05 2019
accepted: 29 05 2019
pubmed: 4 6 2019
medline: 13 6 2020
entrez: 3 6 2019
Statut: ppublish

Résumé

Chronic hepatitis B virus (HBV) infections cause more than 800,000 deaths per year and currently approved treatments do not cure the disease. Because a hallmark of acute infection resolution is the presence of functional CD8

Identifiants

DOI: 10.1016/j.antiviral.2019.05.014 PMID: 31153968 PMC: PMC6660017
pubmed: 31153968
pii: S0166-3542(19)30160-3
doi: 10.1016/j.antiviral.2019.05.014
pmc: PMC6660017
mid: NIHMS1531449
pii:
doi:

Substances chimiques

Hepatitis B Core Antigens 0
Hepatitis B Vaccines 0
Vaccines, Attenuated 0
Vaccines, Virus-Like Particle 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

156-167

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI124006
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Références

J Virol. 2010 Aug;84(15):7513-22
pubmed: 20504927
J Virol. 2007 Mar;81(6):2656-62
pubmed: 17182675
Hepatology. 2017 Oct;66(4):1067-1082
pubmed: 28445927
J Hepatol. 2001 Jun;34(6):917-21
pubmed: 11451177
Gut. 2015 Dec;64(12):1972-84
pubmed: 26048673
J Virol. 2013 Mar;87(5):2969-73
pubmed: 23269785
Curr Opin Immunol. 2015 Oct;36:61-6
pubmed: 26186123
Immunol Cell Biol. 2004 Oct;82(5):539-46
pubmed: 15479440
Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16866-71
pubmed: 25385608
J Biol Chem. 2003 Jan 10;278(2):1201-5
pubmed: 12444091
J Virol. 2009 Apr;83(8):3507-17
pubmed: 19193799
Curr Opin Virol. 2018 Jun;30:58-67
pubmed: 29751272
Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5839-43
pubmed: 18391206
Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10445-9
pubmed: 1660137
Eur J Immunol. 2003 Sep;33(9):2429-38
pubmed: 12938219
Immunity. 2016 May 17;44(5):1204-14
pubmed: 27156385
PLoS One. 2017 Mar 9;12(3):e0173352
pubmed: 28278263
J Exp Med. 2008 Sep 1;205(9):2111-24
pubmed: 18695005
Proc Natl Acad Sci U S A. 2004 Oct 12;101(41):14913-8
pubmed: 15469922
Semin Liver Dis. 2013 May;33(2):103-12
pubmed: 23749666
Curr Opin Virol. 2017 Apr;23:75-81
pubmed: 28453967
Virology. 2015 Jan 15;475:56-65
pubmed: 25462346
J Biol Chem. 2003 Jan 10;278(2):891-5
pubmed: 12417589
Hum Vaccin Immunother. 2017 Dec 2;13(12):2872-2882
pubmed: 28699816
J Virol. 2012 Apr;86(8):4253-61
pubmed: 22345454
Virology. 2003 Jun 20;311(1):81-8
pubmed: 12832205
J Immunol. 1996 May 15;156(10):3687-95
pubmed: 8621903
Clin Vaccine Immunol. 2009 Apr;16(4):488-98
pubmed: 19244472
Cell. 1994 Nov 4;79(3):497-506
pubmed: 7954815
J Clin Invest. 1996 Apr 1;97(7):1655-65
pubmed: 8601631
J Virol Methods. 2005 Jun;126(1-2):207-13
pubmed: 15847939
J Immunol. 2016 Apr 1;196(7):3079-87
pubmed: 26936879
J Virol. 1997 Jan;71(1):65-74
pubmed: 8985324
Adv Exp Med Biol. 2011;780:69-83
pubmed: 21842366
J Virol. 2008 Jan;82(1):207-19
pubmed: 17942549
PLoS Pathog. 2013;9(6):e1003391
pubmed: 23785279
J Virol. 2011 Jun;85(12):5764-72
pubmed: 21490100
Annu Rev Immunol. 1995;13:29-60
pubmed: 7612225
J Virol. 2012 Sep;86(17):9297-310
pubmed: 22718818
J Virol. 2019 Feb 19;93(5):
pubmed: 30541859
Curr Opin Virol. 2018 Jun;30:39-47
pubmed: 29655092
Springer Semin Immunopathol. 2006 Nov;28(3):239-53
pubmed: 16977404
Gut. 2015 Jan;64(1):139-47
pubmed: 24555998
J Virol. 2013 May;87(10):5554-63
pubmed: 23468504
Pathol Biol (Paris). 2010 Aug;58(4):288-95
pubmed: 20382485
PLoS One. 2018 Sep 20;13(9):e0202753
pubmed: 30235286
J Exp Med. 1995 Mar 1;181(3):1047-58
pubmed: 7532675
Curr Opin Immunol. 2016 Aug;41:47-54
pubmed: 27286566
Science. 1986 Dec 12;234(4782):1398-401
pubmed: 3491425
J Biol Chem. 1993 Jan 15;268(2):1332-7
pubmed: 8419335
Hepatol Int. 2011 Jun;5(2):644-53
pubmed: 21484123
Expert Rev Vaccines. 2009 Nov;8(11):1565-73
pubmed: 19863249
Virology. 1996 Apr 15;218(2):406-11
pubmed: 8610469
J Virol. 2007 Feb;81(4):2056-64
pubmed: 17151112
PLoS Pathog. 2014 Jan;10(1):e1003856
pubmed: 24391505
Nature. 1990 Nov 15;348(6298):213-6
pubmed: 1700303
J Exp Med. 2017 Jun 5;214(6):1567-1580
pubmed: 28526759
Methods Mol Biol. 2017;1540:237-247
pubmed: 27975322
Gut. 2015 Dec;64(12):1961-71
pubmed: 25429051
J Virol. 2005 Dec;79(24):15043-53
pubmed: 16306575
J Infect Dis. 2015 Oct 1;212 Suppl 2:S443-51
pubmed: 26109675
Cell Mol Immunol. 2014 Jan;11(1):71-8
pubmed: 24076617
Lancet Gastroenterol Hepatol. 2018 Mar;3(3):192-202
pubmed: 29870733
Trends Mol Med. 2004 May;10(5):210-6
pubmed: 15121047
Cell. 2001 Sep 7;106(5):539-49
pubmed: 11551502
J Virol. 2015 Oct;89(20):10407-15
pubmed: 26246574
Clin Vaccine Immunol. 2017 Nov 6;24(11):
pubmed: 28931520

Auteurs

Carolina Chiale (C)

Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY, USA.

Safiehkhatoon Moshkani (S)

Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY, USA.

John K Rose (JK)

Department of Pathology, Yale School of Medicine, New Haven, CT, USA.

Michael D Robek (MD)

Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY, USA. Electronic address: robekm@amc.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Meal Timing and Anthropometric and Metabolic Outcomes: A Systematic Review and Meta-Analysis.

Hiu Yee Liu, Ashley A Eso, Nathan Cook et al.
1.00
Humans Meals Time Factors Female Adult

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Heterologous prime-boost immunization with...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Lymphocytes T CD8+ › Heterologous prime-boost immunization with...
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Vecteurs génétiques › Heterologous prime-boost immunization with...
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies du foie › Hépatite › Hépatites virales humaines › Hépatite B › Heterologous prime-boost immunization with...
questionsmedicales.fr › Facteurs biologiques › Antigènes › Antigènes viraux › Antigènes d'hépatite virale › Antigènes de l'hépatite virale B › Antigènes de la nucléocapside du virus de l'hépatite virale B › Heterologous prime-boost immunization with...
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins antiviraux › Vaccins contre les hépatites virales › Vaccins anti-hépatite B › Heterologous prime-boost immunization with...
questionsmedicales.fr › Virus › Virus de l'hépatite › Hepadnaviridae › Orthohepadnavirus › Virus de l'hépatite B › Heterologous prime-boost immunization with...
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Rappel de vaccin › Heterologous prime-boost immunization with...
questionsmedicales.fr › Système digestif › Foie › Heterologous prime-boost immunization with...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Heterologous prime-boost immunization with...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Lignées consanguines de souris › Souris de lignée C57BL › Heterologous prime-boost immunization with...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Togaviridae › Alphavirus › Virus de la forêt de Semliki › Heterologous prime-boost immunization with...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pratiques en santé publique › Prévention primaire › Immunisation › Vaccination › Heterologous prime-boost immunization with...
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins atténués › Heterologous prime-boost immunization with...
questionsmedicales.fr › Facteurs biologiques › Antigènes › Vaccins synthétiques › Vaccins à pseudo-particules virales › Heterologous prime-boost immunization with...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN de polarité négative › Mononegavirales › Rhabdoviridae › Vesiculovirus › Virus de la stomatite vésiculeuse de type Indiana › Heterologous prime-boost immunization with...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN de polarité négative › Mononegavirales › Rhabdoviridae › Vesiculovirus › Heterologous prime-boost immunization with...
questionsmedicales.fr › Phénomènes microbiologiques › Phénomènes physiologiques viraux › Réplication virale › Heterologous prime-boost immunization with...